Antithymocyte Globulin and Azathioprine Versus Basiliximab and Mycophenolate Mofetil in Living Donor Kidney Transplantation

NCT03789006 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplant Rejection

Interventions

DRUG: Antithymocyte Immunoglobulin (Rabbit)
DRUG: Interleukin 2 Receptor Antagonist

Sponsor

University of Khartoum

Collaborators

[object Object]